DRI Capital is an investment firm based in Toronto, Canada and was founded in 1992. The firm manages private equity funds that purchase royalties from pharmaceutical and biotechnology firms, research institutions, universities and inventors. It considers investments in royalty entitlements on medical devices, diagnostic products and life science tools and technologies. It is an indirect subsidiary of Persis Holdings Ltd., formerly known as Inwest Investments.